I’m bemused by people who reference 10 years ago as their investment timeline in AVR.
Back then anyone that invested didn’t TAVR as a consideration, and I assume it was all about the vaccine story.
That investment failed and by some good fortune instead of going belly up you got to stay in the game, yes diluted but if you got onboard the new direction of TAVR then there was very chance to average down to be significantly in front today.
Me and my mates have been hi-5ing in 2022 and expect even greater developments in 2023.
Ann: FDA Approves Early Feasibility Study for DurAVR THV System, page-39
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.05 |
Change
0.000(0.00%) |
Mkt cap ! $327.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 191 | $17.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.55 | 2592 | 2 |
View Market Depth
| Last trade - 16.14pm 23/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable